C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
12/2007
12/26/2007	CN101092402A New compound in sulfonyl ureas, and medicine use
12/26/2007	CN101092399A Method for preparing ionic liquid with anion being as ion in halogen family
12/26/2007	CN101091923A Carbon nitrogen coupling reaction catalyst composed of heterocycle functional group 1,3 diketone and halogenated univalence copper, and preparation method
12/26/2007	CN101091488A Composition for controlling harmful bio-organisms and methodfor controlling harmful bio-organisms using the same
12/26/2007	CN100357291C Method for synthesizing olefin type imidacloprid from imidacloprid by microorganism transformation
12/26/2007	CN100357283C Methionyl aminopeptidase inhibitor
12/25/2007	US7312359 Tetralin and indane derivatives and uses thereof
12/25/2007	US7312358 Dysmenorrhea; congestive heart failure; liver disorders; vision defects
12/25/2007	US7312244 For therapy of cancer, as antitumor agent
12/25/2007	US7312238 Nonsedating α-2 agonists
12/25/2007	US7312235 Anticoagulants
12/25/2007	US7311736 Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetra-azapentamethine compounds
12/21/2007	WO2007144725A2 SYNTHESIS AND EVALUATION OF 18F-LABELLED ALKYL-1-[(R)-1-PHENYLETHYL]-1H-IMIDAZOLE-5-CARBOXYLATE AS A TRACER FOR THE QUANTIFICATION OF β-11-HYDROXYLASE ENZYME IN THE ADRENAL GLANDS
12/21/2007	WO2007143951A1 COMPOUNDS WITH THE ACTIVITY OF PPARγ AGONIST AND APPLICATION THEREOF
12/21/2007	WO2007143822A1 Sulfamide and sulfamate derivatives as histone deacetylase inhibitors
12/21/2007	WO2007115269A3 Orally bioavailable caffeic acid related anticancer drugs
12/21/2007	WO2002072068A3 Lipids, lipid compositions, liposomes, and lipoplexes
12/20/2007	US20070293684 Method of preparing imidazolium surfactants
12/20/2007	US20070293680 For the preparation of (R)-(+)-6-[amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl) methyl]-4-(3-chlorophenyl)-1-methyl2(1H)-quinolinone; farnesyl tranferase inhibitory activity
12/20/2007	US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia
12/20/2007	US20070293526 Arylsulfonyl naphthalene derivatives and uses thereof
12/20/2007	US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
12/20/2007	US20070293495 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
12/20/2007	US20070293477 Novel Compounds
12/20/2007	US20070293423 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
12/19/2007	EP1867730A1 Process for production of optically active hydroxymethyl -substituted phenylalanine
12/19/2007	EP1867637A2 Transesterification process for production of (meth)acrylate ester monomers
12/19/2007	EP1866298A2 Hydroxysteroid dehydrogenase inhibitors
12/19/2007	EP1866278A1 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists
12/19/2007	EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/19/2007	EP1032556B1 Pharmaceutically active compounds and methods of use
12/19/2007	CN101090952A Compositions, redox couples and uses thereof
12/19/2007	CN101090892A Sulphonamide derivatives, their preparation and their therapeutic application
12/19/2007	CN101090883A Substituted hydroxyethylamines
12/19/2007	CN101090739A 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri)
12/19/2007	CN101088990A Transesterification process for production of (meth)acrylate ester monomers
12/19/2007	CN100355737C Pyruvic acid type ionic liquid and its preparing method
12/19/2007	CN100355728C Inhibitors of dipeptidyl peptidase IV
12/18/2007	US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
12/18/2007	US7309791 Methyl (2S)-3-{4-[(3,5-dimethylisoxazol-4-yl)methylenoxy]phenyl}-2-[(4-phenyl-1,3-thiazol-2-yl)amino]propionate; (2S)-3-{4-[(3,5-dimethylisoxazol-4-yl)methylenoxy]phenyl}-2-[(4-phenyl-1,3-thiazol-2-yl)amino]propionic acid; bind to PPAR gamma receptor and modify its activity
12/18/2007	US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists
12/13/2007	WO2007141441A1 Improved monomers and polymers carrying imidazole and benzimidazole groupings, and proton exchange membrane containing the same for the production of a fuel cell
12/13/2007	CA2654784A1 Substituted phenylacetic acids as dp-2 antagonists
12/12/2007	EP1864970A1 Process for producing disulfonyl fluoride compound
12/12/2007	EP1863770A2 Ring closing and related methods and intermediates
12/12/2007	EP0819123B1 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity
12/12/2007	CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
12/12/2007	CN101085772A Compound with PPARgamma excitant activity and application thereof
12/11/2007	US7307097 Chemical compounds
12/11/2007	CA2393271C Retroviral protease inhibiting compounds
12/06/2007	WO2007139001A1 Substituted phenylethynyl gold-nitrogenated heterocyclic carbene complex
12/06/2007	WO2007138343A1 N-phenylamidines as 5-ht2a receptor antagonists
12/06/2007	WO2007138307A2 Process for removing sulfur-containing acids from crude oil
12/06/2007	WO2007138242A1 Biphenyl derivatives and their use in treating hepatitis c
12/06/2007	WO2007068894A3 Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
12/06/2007	WO2006067428A3 1, 2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands
12/06/2007	US20070282148 Organometallic ruthenium complexes and related methods for the preparation of tetra-substituted and other hindered olefins
12/06/2007	US20070282111 An aryl compound with an active group is reacted with an amine compound in the presence of a base by means of a catalyst which comprises a palladium compound having a tertiary phosphine group and a phase-transfer catalyst; highly selective and efficient
12/06/2007	US20070281983 Creatine analog prodrugs, compositions and uses thereof
12/06/2007	US20070281974 1 h-imidazole derivatives as cannabinoid receptor modulators
12/06/2007	US20070281952 Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists
12/06/2007	CA2653924A1 Biphenyl derivatives and their use in treating hepatitis c
12/05/2007	EP1862451A1 Adamantane derivatives for the treatment of inflammatory diseases
12/05/2007	EP1862444A2 Ether compounds, compositions, and uses thereof
12/05/2007	EP1861468A1 Method and use of acidified modified polymers to bind biocides in paints
12/05/2007	EP1861384A1 11-beta-hydroxysteroid dehydrogenase inhibitors
12/05/2007	EP1861376A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments
12/05/2007	EP1861079A1 Arylsulfonyl benzyl ethers as 5-ht2a antagonists
12/05/2007	EP1438294B1 Developer constituents and their use for dying keratin fibers
12/05/2007	EP1362844B1 Benzylamine analogue
12/05/2007	EP1169294B1 Pharmaceutical compounds
12/05/2007	CN101084208A Aromatic amides as inhibitors of c-fms kinase
12/05/2007	CN101084201A Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists
12/05/2007	CN101084196A Process for producing n-halogenated organic compounds
12/05/2007	CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
12/04/2007	US7304164 Melt-cast explosive material
12/04/2007	US7304093 Ketone compounds and compositions for cholesterol management and related uses
12/04/2007	US7304086 Inhibitors of glutaminyl cyclase
12/04/2007	US7304083 2-iminoimidazole derivatives (2)
12/04/2007	CA2282563C Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates
12/04/2007	CA2210533C Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors
12/04/2007	CA2202495C Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
11/2007
11/29/2007	WO2007136059A1 Composition for diagnosing amyloid-related disease
11/29/2007	WO2007135969A1 Urea type cinnamide derivative
11/29/2007	WO2007134862A1 Substituted arylimidaz0l0ne and triaz0l0ne as inhibitors of vasopressin receptors
11/29/2007	WO2007120647A3 Compositions useful as inhibitors of voltage-gated sodium channels
11/29/2007	WO2007092190A3 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
11/29/2007	WO2007090749A3 Benzamide and heteroarene derivatives as cetp inhibitors
11/29/2007	WO2007087434A3 Method for the production of copper and zinc mono-and bi-metallic imidazolates
11/29/2007	WO2007062332A3 Novel intermediates and their use
11/29/2007	WO2007014619A8 Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
11/29/2007	US20070276143 Method for producing optically active compound
11/29/2007	US20070276138 Modulators of peroxisome proliferator activated receptors
11/29/2007	US20070276011 Plasminogen Activator Inhibitor-1 Inhibitor
11/29/2007	US20070275932 Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
11/29/2007	DE102006024024A1 Substituierte Arylimidazolone und -triazolone sowie ihre Verwendung Substituted Arylimidazolone and -triazolone and their use
11/29/2007	CA2652440A1 Composition for diagnosis of amyloid-related disease
11/29/2007	CA2651396A1 Urea type cinnamide derivative
11/28/2007	EP1859798A1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
11/28/2007	EP1858859A1 Process for the preparation of optically active (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine

1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 345